Steven Myint
Chief Executive Officer chez Moewin Associates Ltd.
Profil
Steven Myint is currently the Chairman at Inex Innovations Exchange Pte Ltd, Global Medical Director at GlaxoSmithKline Oy, Managing Director at Moewin Associates Ltd., and Non-Executive Director at Aplagon Oy.
He previously served as Chairman at Plexpress Oy and Independent Director at Vickers Vantage Corp.
I.
He was also the Chief Medical Officer and SVP-Research & Development at BTG International Ltd.
from 2007 to 2009.
Additionally, he held academic positions as a Professor of Microbiology & Immunology at the University of Leicester and as a Professor and Dean of Medicine & Health at the University of Surrey.
He holds a doctorate degree from both the University of London and Julius-Maximilians-Universität Würzburg.
Postes actifs de Steven Myint
| Sociétés | Poste | Début |
|---|---|---|
Glaxosmithkline Oy
 Glaxosmithkline Oy Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Oy is a Finnish company that manufactures pharmaceutical products. The private company is based in Espoo, Finland. | Chief Tech/Sci/R&D Officer | - |
| Moewin Associates Ltd. | Chief Executive Officer | - |
Aplagon Oy
 Aplagon Oy Financial ConglomeratesFinance Aplagon Oy provides pharmaceutical discovery and development services. It develops locally acting antithrombotic products (APACs). The company was founded by Riitta Lassila and Yrjo Sakari Lassila in 2009 and is headquartered in Helsinki, Finland. | Director/Board Member | - |
Inex Innovations Exchange Pte Ltd
 Inex Innovations Exchange Pte Ltd Medical/Nursing ServicesHealth Services Inex Innovations Exchange Pte Ltd provides molecular diagnostics services. The firm specializes in FemTech – technology that addresses specific concerns on women’s health, such as reproductive health and ovarian cancer. The company was founded by Mahesh Choolani, Sidney Yee, Khalil Razvi and Arijit Biswas in 2006 and is headquartered in Singapore. | Chairman | - |
Anciens postes connus de Steven Myint
| Sociétés | Poste | Fin |
|---|---|---|
BTG International Ltd.
 BTG International Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Boston Scientific Corp., BTG International Ltd. is a British company that engages in research and experimental development on natural sciences and engineering. The private company is based in London, UK and was founded in 1991. | Chief Tech/Sci/R&D Officer | 01/01/2009 |
| VICS VANT | Director/Board Member | - |
| University of Surrey | Corporate Officer/Principal | - |
| University of Leicester | Corporate Officer/Principal | - |
Plexpress Oy
 Plexpress Oy Pharmaceuticals: GenericHealth Technology Plexpress offers high-content gene expression analysis for cell biology research, enabling higher throughput and providing more information than competitors' products. Plexpress analysis service is a cost and time efficient solution for large screens in preclinical drug discovery studies, safety assays and yeast studies. Plexpress was established as a spinoff from the Finnish Technology Research Center VTT in 2007. Including R&D at VTT, the company's TRAC technology has been developed continuously for nearly 10 years and it has been documented in over 15 publications. The technology was originally developed for demanding bioprocess applications, which required a very robust solution for gene expression analysis. The principal developers of the technology, Hans Soderlund and Jari Rautio, are still closely involved with the company as Chairman of the Scientific Advisory Board and VP of R&D, respectively. Since starting operations in 2008, the company has carried out projects using the TRAC technology in the fields of pharmaceutical development and academic research. | Chairman | - |
Formation de Steven Myint
| University of London | Doctorate Degree |
| Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
BTG International Ltd.
BTG International Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Boston Scientific Corp., BTG International Ltd. is a British company that engages in research and experimental development on natural sciences and engineering. The private company is based in London, UK and was founded in 1991. | Commercial Services |
Plexpress Oy
Plexpress Oy Pharmaceuticals: GenericHealth Technology Plexpress offers high-content gene expression analysis for cell biology research, enabling higher throughput and providing more information than competitors' products. Plexpress analysis service is a cost and time efficient solution for large screens in preclinical drug discovery studies, safety assays and yeast studies. Plexpress was established as a spinoff from the Finnish Technology Research Center VTT in 2007. Including R&D at VTT, the company's TRAC technology has been developed continuously for nearly 10 years and it has been documented in over 15 publications. The technology was originally developed for demanding bioprocess applications, which required a very robust solution for gene expression analysis. The principal developers of the technology, Hans Soderlund and Jari Rautio, are still closely involved with the company as Chairman of the Scientific Advisory Board and VP of R&D, respectively. Since starting operations in 2008, the company has carried out projects using the TRAC technology in the fields of pharmaceutical development and academic research. | Health Technology |
Glaxosmithkline Oy
Glaxosmithkline Oy Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Oy is a Finnish company that manufactures pharmaceutical products. The private company is based in Espoo, Finland. | Health Technology |
| Moewin Associates Ltd. | |
Aplagon Oy
Aplagon Oy Financial ConglomeratesFinance Aplagon Oy provides pharmaceutical discovery and development services. It develops locally acting antithrombotic products (APACs). The company was founded by Riitta Lassila and Yrjo Sakari Lassila in 2009 and is headquartered in Helsinki, Finland. | Finance |
Inex Innovations Exchange Pte Ltd
Inex Innovations Exchange Pte Ltd Medical/Nursing ServicesHealth Services Inex Innovations Exchange Pte Ltd provides molecular diagnostics services. The firm specializes in FemTech – technology that addresses specific concerns on women’s health, such as reproductive health and ovarian cancer. The company was founded by Mahesh Choolani, Sidney Yee, Khalil Razvi and Arijit Biswas in 2006 and is headquartered in Singapore. | Health Services |
Vickers Vantage Corp. I
 Vickers Vantage Corp. I Financial ConglomeratesFinance Vickers Vantage Corp. I is a blank check company. It is created for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The company was founded on February 21, 2020 and is headquartered in Singapore. | Finance |
